Aminosalicylic Acid use while Breastfeeding
Drugs containing Aminosalicylic Acid: Paser
Aminosalicylic Acid Levels and Effects while Breastfeeding
Summary of Use during Lactation
Limited information indicates that maternal aminosalicylic acid therapy produces low levels in milk and would not be expected to cause any adverse effects in breastfed infants, especially if the infant is older than 2 months. Exclusively breastfed infants should be monitored for rare instances of jaundice, gastrointestinal disturbances, hypokalemia, thrombocytopenia, hemolysis and hypokalemia if this drug is used during lactation.
Maternal Levels. One woman who was lactating, but not breastfeeding (time postpartum not stated) took a single 4 gram oral dose of aminosalicylic acid. A peak milk level of 1.1 mg/L occurred at 3 hours after the dose. The drug's half-life in milk was estimated to be 2.5 hours. Using these data, a fully breastfed infant would receive a maximum of about 0.25% of the maternal weight-adjusted dosage.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Aminosalicylic acid was used as part of multi-drug regimens to treat 2 pregnant women with multidrug-resistant tuberculosis throughout pregnancy and postpartum. Their two infants were breastfed (extent and duration not stated). At age 1.8 and 4.6 years, the children were developing normally, except for except for a mild speech delay in one and At age 1.8 years, failure to thrive in the other, possibly due to tuberculosis contracted after birth.
Possible Effects on Lactation
Relevant published information was not found as of the revision date.
1. Holdiness MR. Antituberculosis drugs and breast-feeding. Arch Intern Med. 1984;144:1888. Letter. PMID: 15889370
2. Drobac PC, del Castillo H, Sweetland A et al. Treatment of multidrug-resistant tuberculosis during pregnancy: long-term follow-up of 6 children with intrauterine exposure to second-line agents. Clin Infect Dis. 2005;40:1689-92. PMID: 15889370
Aminosalicylic Acid Identification
CAS Registry Number
- Antitubercular Agents
LactMed Record Number
Information from the National Library of Medicine's LactMed Database.
Last Revision Date
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- Aminosalicylic acid use during Pregnancy
- Aminosalicylic acid controlled-release granules packet Consumer Information
- Breastfeeding Support Group
- Safe Medications during Breastfeeding
- Medicine use while Breastfeeding
- Medicine use during Pregnancy